NCT07061470 · Phase 1 · NOT YET RECRUITING
A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep
This trial is testing whether a daily iron supplement (ferrous sulfate, available over the counter) reduces restless sleep and eases ADHD symptoms in children and teens. Researchers will compare it against a placebo over three months, tracking sleep with wrist and leg monitors and parent ratings. This is a Phase 1 trial, meaning the primary focus is on early safety and tolerability, not yet a proven or approved treatment.
You may qualify if
- clinically diagnosed with ADHD
- have blood ferritin level below 50ng/mL
- have parent- or self-reported restless sleep
You're excluded if
- presence of any chronic medical or genetic condition that could impact iron metabolism
- presence of moderate to severe Obstructive Sleep Apnea
- having received Iron supplementation treatment within the past 3 months
- having blood ferritin level indicative of anemia that requires immediate treatment
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-05-04